Items where Author is "Yardley, V"
![]() | Up a level |
Number of items: 96.
2018
Guo, M;
Wang, K;
Qiao, N;
Yardley, V;
Li, M;
(2018)
Investigating Permeation Behavior of Flufenamic Acid Cocrystals Using a Dissolution and Permeation System.
Molecular pharmaceutics.
ISSN 1543-8384
DOI: https://doi.org/10.1021/acs.molpharmaceut.8b00670
Thompson, AM;
O'Connor, PD;
Marshall, AJ;
Blaser, A;
Yardley, V;
Maes, L;
Gupta, S;
Launay, D;
Braillard, S;
Chatelain, E;
+5 more...
Wan, B;
Franzblau, SG;
Ma, Z;
Cooper, CB;
Denny, WA;
(2018)
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.
Journal of medicinal chemistry.
ISSN 0022-2623
DOI: https://doi.org/10.1021/acs.jmedchem.7b01581
Van Bocxlaer, K;
Gaukel, E;
Hauser, D;
Park, SH;
Schock, S;
Yardley, V;
Randolph, R;
Plattner, JJ;
Merchant, T;
Croft, SL;
+2 more...
Jacobs, RT;
Wring, SA;
(2018)
Topical treatment for cutaneous leishmaniasis - dermato-pharmacokinetic led optimisation of benzoxaboroles.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.02419-17
Wijnant, GJ;
Van Bocxlaer, K;
Fortes Francisco, A;
Yardley, V;
Harris, A;
Alavijeh, M;
Murdan, S;
Croft, SL;
(2018)
Local skin inflammation in cutaneous leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00631-18
Wijnant, GJ;
Van Bocxlaer, K;
Yardley, V;
Harris, A;
Alavijeh, M;
Silva-Pedrosa, R;
Antunes, S;
Mauricio, I;
Murdan, S;
Croft, SL;
(2018)
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis.
International journal for parasitology Drugs and drug resistance, 8 (2).
pp. 223-228.
ISSN 2211-3207
DOI: https://doi.org/10.1016/j.ijpddr.2018.04.001
Yardley, V;
Koniordou, M;
(2018)
Chapter 4: Drug Assay Methodology in Leishmaniasis: From the Microplate to Image Analysis.
In: UNSPECIFIED, (ed.)
Drug Discovery for Leishmaniasis.
Royal Society of Chemistry, pp. 55-76.
ISBN 9781782628897
DOI: https://doi.org/10.1039/9781788010177
Full text not available from this repository.
2017
Basilico, N;
Parapini, S;
Sparatore, A;
Romeo, S;
Misiano, P;
Vivas, L;
Yardley, V;
Croft, SL;
Habluetzel, A;
Lucantoni, L;
+8 more...
Renia, L;
Russell, B;
Suwanarusk, R;
Nosten, F;
Dondio, G;
Bigogno, C;
Jabes, D;
Taramelli, D;
(2017)
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
Molecules (Basel, Switzerland), 22 (12).
ISSN 1420-3049
DOI: https://doi.org/10.3390/molecules22122102
Bhambra, AS;
Ruparelia, KC;
Tan, HL;
Tasdemir, D;
Burrell-Saward, H;
Yardley, V;
Beresford, KJ;
Arroo, RR;
(2017)
Synthesis and antitrypanosomal activities of novel pyridylchalcones.
European journal of medicinal chemistry, 128.
pp. 213-218.
ISSN 0223-5234
DOI: https://doi.org/10.1016/j.ejmech.2017.01.027
Thompson, AM;
O'Connor, PD;
Marshall, AJ;
Yardley, V;
Maes, L;
Gupta, S;
Launay, D;
Braillard, S;
Chatelain, E;
Franzblau, SG;
+5 more...
Wan, B;
Wang, Y;
Ma, Z;
Cooper, CB;
Denny, WA;
(2017)
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.
Journal of medicinal chemistry, 60 (10).
pp. 4212-4233.
ISSN 0022-2623
DOI: https://doi.org/10.1021/acs.jmedchem.7b00034
Wijnant, GJ;
Van Bocxlaer, K;
Yardley, V;
Harris, A;
Murdan, S;
Croft, SL;
(2017)
AmBisome® treatment of murine cutaneous leishmaniasis: relation between skin pharmacokinetics and efficacy.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.02009-17
Wijnant, GJ;
Van Bocxlaer, K;
Yardley, V;
Murdan, S;
Croft, S;
(2017)
Efficacy of a Paromomycin plus Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00358-17
2016
Daunes, S;
Yardley, V;
Croft, SL;
D'Silva, C;
(2016)
Antiprotozoal glutathione derivatives with flagellar membrane binding activity against T. brucei rhodesiense.
Bioorganic & medicinal chemistry.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2016.12.016
Khan, NH;
Bari, AU;
Hashim, R;
Khan, I;
Muneer, A;
Shah, A;
Wahid, S;
Yardley, V;
O'Neil, B;
Sutherland, CJ;
(2016)
Cutaneous Leishmaniasis in Khyber Pakhtunkhwa Province of Pakistan: Clinical Diversity and Species-Level Diagnosis.
The American journal of tropical medicine and hygiene.
ISSN 0002-9637
DOI: https://doi.org/10.4269/ajtmh.16-0343
Tegazzini, D;
Díaz, R;
Aguilar, F;
Peña, I;
Presa, JL;
Yardley, V;
Martin, JJ;
Coteron, JM;
Croft, SL;
Cantizani, J;
(2016)
A replicative in vitro assay for drug discovery against Leishmania donovani.
Antimicrobial agents and chemotherapy, 60 (6).
pp. 3524-32.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.01781-15
Thompson, AM;
O'Connor, PD;
Blaser, A;
Yardley, V;
Maes, L;
Gupta, S;
Launay, D;
Martin, D;
Franzblau, SG;
Wan, B;
+3 more...
Wang, Y;
Ma, Z;
Denny, WA;
(2016)
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis.
Journal of medicinal chemistry.
ISSN 0022-2623
DOI: https://doi.org/10.1021/acs.jmedchem.5b01699
Van Bocxlaer, K;
Yardley, V;
Murdan, S;
Croft, SL;
(2016)
Drug permeation and barrier damage in Leishmania-infected mouse skin.
The Journal of antimicrobial chemotherapy, 71 (6).
pp. 1578-85.
ISSN 0305-7453
DOI: https://doi.org/10.1093/jac/dkw012
Full text not available from this repository.
Van Bocxlaer, K;
Yardley, V;
Murdan, S;
Croft, SL;
(2016)
Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model.
The Journal of pharmacy and pharmacology, 68 (7).
pp. 862-72.
ISSN 0022-3573
DOI: https://doi.org/10.1111/jphp.12548
Yizengaw, E;
Getahun, M;
Tajebe, F;
Cruz Cervera, E;
Adem, E;
Mesfin, G;
Hailu, A;
Van der Auwera, G;
Yardley, V;
Lemma, M;
+10 more...
Skhedy, Z;
Diro, E;
Yeshanew, A;
Melkamu, R;
Mengesha, B;
Modolell, M;
Munder, M;
Müller, I;
Takele, Y;
Kropf, P;
(2016)
Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.
Frontiers in immunology, 7.
p. 517.
ISSN 1664-3224
DOI: https://doi.org/10.3389/fimmu.2016.00517
2015
Bhambra, AS;
Edgar, M;
Elsegood, MR;
Li, Y;
Weaver, GW;
Arroo, RR;
Yardley, V;
Burrell-Saward, H;
Krystof, V;
(2015)
Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes.
European journal of medicinal chemistry, 108.
pp. 347-353.
ISSN 0223-5234
DOI: https://doi.org/10.1016/j.ejmech.2015.11.043
Full text not available from this repository.
Carvalho, L;
Martínez-García, M;
Pérez-Victoria, I;
Manzano, JI;
Yardley, V;
Gamarro, F;
Pérez-Victoria, JM;
(2015)
The oral antimalarial drug tafenoquine shows activity against Trypanosoma brucei.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00879-15
Full text not available from this repository.
2014
Corware, K;
Yardley, V;
Mack, C;
Schuster, S;
Al-Hassi, H;
Herath, S;
Bergin, P;
Modolell, M;
Munder, M;
Müller, I;
+1 more...
Kropf, P;
(2014)
Protein energy malnutrition increases arginase activity in monocytes and macrophages.
Nutrition & metabolism, 11 (1).
p. 51.
ISSN 1743-7075
DOI: https://doi.org/10.1186/1743-7075-11-51
Gupta, S;
Yardley, V;
Vishwakarma, P;
Shivahare, R;
Sharma, B;
Launay, D;
Martin, D;
Puri, SK;
(2014)
Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
The Journal of antimicrobial chemotherapy.
ISSN 0305-7453
DOI: https://doi.org/10.1093/jac/dku422
Full text not available from this repository.
Les, KA;
Mohamed-Ahmed, AHA;
Balan, S;
Choi, J.-, W;
Martin, D;
Yardley, V;
Powell, K;
Godwin, A;
Brocchini, S;
(2014)
Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases.
Polymer chemistry, 5 (3).
pp. 1037-1048.
ISSN 1759-9954
DOI: https://doi.org/10.1039/c3py01051a
Full text not available from this repository.
Sanderson, L;
Yardley, V;
Croft, SL;
(2014)
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
The Journal of antimicrobial chemotherapy.
ISSN 0305-7453
DOI: https://doi.org/10.1093/jac/dku069
Full text not available from this repository.
2013
Baiocco, P;
Poce, G;
Alfonso, S;
Cocozza, M;
Porretta, GC;
Colotti, G;
Biava, M;
Moraca, F;
Botta, M;
Yardley, V;
+4 more...
Fiorillo, A;
Lantella, A;
Malatesta, F;
Ilari, A;
(2013)
Inhibition of Leishmania infantum Trypanothione Reductase by Azole-Based Compounds: a Comparative Analysis with Its Physiological Substrate by X-ray Crystallography.
ChemMedChem, 8 (7).
pp. 1175-1183.
ISSN 1860-7179
DOI: https://doi.org/10.1002/cmdc.201300176
Full text not available from this repository.
Mohamed-Ahmed, AbeerHA;
Seifert, Karin;
Yardley, Vanessa;
Burrell-Saward, Hollie;
Brocchini, Stephen;
Croft, SimonL;
(2013)
Antileishmanial Activity, Uptake, and Biodistribution of an Amphotericin B and Poly(alpha-Glutamic Acid) Complex.
Antimicrobial agents and chemotherapy, 57 (10).
pp. 4608-4614.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.02343-12
Full text not available from this repository.
2012
Peña, S;
Scarone, L;
Manta, E;
Stewart, L;
Yardley, V;
Croft, S;
Serra, G;
(2012)
Synthesis of a Microcystis aeruginosa predicted metabolite with antimalarial activity.
Bioorganic & medicinal chemistry letters, 22 (15).
pp. 4994-7.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2012.06.028
Full text not available from this repository.
2011
Kobarfard, F;
Yardley, V;
Little, S;
Daryaee, F;
Chibale, K;
(2011)
Synthesis of Aminoquinoline-based Aminoalcohols and Oxazolidinones and Their Antiplasmodial Activity.
Chemical biology & drug design.
ISSN 1747-0277
http://researchonline.lshtm.ac.uk/id/eprint/19762
Full text not available from this repository.
Kobarfard, F;
Yardley, V;
Little, S;
Daryaee, F;
Chibale, K;
(2011)
Synthesis of Aminoquinoline-based Aminoalcohols and Oxazolidinones and Their Antiplasmodial Activity.
Chemical biology & drug design.
ISSN 1747-0277
DOI: https://doi.org/10.1111/j.1747-0285.2011.01278.x
Full text not available from this repository.
Muller, T;
Johann, L;
Jannack, B;
Bruckner, M;
Lanfranchi, DA;
Bauer, H;
Sanchez, C;
Yardley, V;
Deregnaucourt, C;
Schrevel, J;
+3 more...
Lanzer, M;
Schirmer, RH;
Davioud-Charvet, E;
(2011)
Glutathione Reductase-Catalyzed Cascade of Redox Reactions To Bioactivate Potent Antimalarial 1,4-Naphthoquinones - A New Strategy to Combat Malarial Parasites.
Journal of the American Chemical Society, 133 (30).
pp. 11557-11571.
ISSN 0002-7863
DOI: https://doi.org/10.1021/ja201729z
Full text not available from this repository.
2010
Abazid, Nizar;
(2010)
Treatment of localised cutaneous Leishmania tropica infection in Aleppo, Syria and drug sensitivity of clinical isolates.
PhD thesis, London School of Hygiene & Tropical Medicine.
DOI: https://doi.org/10.17037/PUBS.01742275
Blackie, MAL;
Yardley, V;
Chibale, K;
(2010)
Synthesis and evaluation of phenylequine for antimalarial activity in vitro and in vivo.
Bioorganic & medicinal chemistry letters, 20 (3).
pp. 1078-1080.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2009.12.030
Full text not available from this repository.
Haque, A;
Stanley, AC;
Amante, FH;
Rivera, FD;
Zhou, YH;
Kuns, RD;
Yardley, V;
Sakaguchi, S;
Hill, GR;
Engwerda, CR;
(2010)
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4(+) T Cell Responses Enhances Antiparasitic Immunity.
Journal of immunology (Baltimore, Md, 184 (5).
pp. 2583-2592.
ISSN 0022-1767
DOI: https://doi.org/10.4049/jimmunol.0903080
Full text not available from this repository.
Yang, M;
Arai, C;
Md, AB;
Lu, J;
Ge, JF;
Pudhom, K;
Takasu, K;
Kasai, K;
Kaiser, M;
Brun, R;
+3 more...
Yardley, V;
Itoh, I;
Ihara, M;
(2010)
Fluorinated Rhodacyanine (SJL-01) Possessing High Efficacy for Visceral Leishmaniasis (VL).
Journal of medicinal chemistry, 53 (1).
pp. 368-373.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm9013086
Full text not available from this repository.
Yardley, V;
Gamarro, F;
Croft, SL;
(2010)
Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.
Antimicrobial agents and chemotherapy, 54 (12).
pp. 5356-8.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00985-10
Full text not available from this repository.
2009
Gemma, S;
Campiani, G;
Butini, S;
Joshi, BP;
Kukreja, G;
Coccone, SS;
Bernetti, M;
Persico, M;
Nacci, V;
Fiorini, I;
+14 more...
Novellino, E;
Taramelli, D;
Basilico, N;
Parapini, S;
Yardley, V;
Croft, S;
Keller-Maerki, S;
Rottmann, M;
Brun, R;
Coletta, M;
Marini, S;
Guiso, G;
Caccia, S;
Fattorusso, C;
(2009)
Combining 4-Aminoquinoline- and Clotrimazole-Based Pharmacophores toward Innovative and Potent Hybrid Antimalarials.
Journal of medicinal chemistry, 52 (2).
pp. 502-513.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm801352s
Full text not available from this repository.
Guglielmo, S;
Bertinaria, M;
Rolando, B;
Crosetti, M;
Fruttero, R;
Yardley, V;
Croft, SL;
Gasco, A;
(2009)
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
European journal of medicinal chemistry, 44 (12).
pp. 5071-5079.
ISSN 0223-5234
DOI: https://doi.org/10.1016/j.ejmech.2009.09.012
Full text not available from this repository.
2008
Coro, J;
Little, S;
Yardley, V;
Suarez, M;
Rodriguez, H;
Martin, N;
Perez-Pineiro, R;
(2008)
Synthesis and Antiprotozoal Evaluation of New N-4-(Benzyl)spermidyl-linked bis(1,3,5-thiadiazinane-2-thiones).
Archiv der Pharmazie, 341 (11).
pp. 708-713.
ISSN 0365-6233
DOI: https://doi.org/10.1002/ardp.200800011
Full text not available from this repository.
Decuypere, S;
Vanaerschot, M;
Rijal, S;
Yardley, V;
Maes, L;
de Doncker, S;
Chappuis, F;
Dujardin, JC;
(2008)
Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation.
Parasitology, 135 (2).
pp. 183-194.
ISSN 0031-1820
DOI: https://doi.org/10.1017/S0031182007003782
Fattorusso, C;
Campiani, G;
Kukreja, G;
Persico, M;
Butini, S;
Romano, MP;
Altarelli, M;
Rost, S;
Brindisi, M;
Savini, L;
+10 more...
Novellino, E;
Nacci, V;
Fattorusso, E;
Parapini, S;
Basilico, N;
Taramelli, D;
Yardley, V;
Croft, S;
Borriello, M;
Gemma, S;
(2008)
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
Journal of medicinal chemistry, 51 (5).
pp. 1333-1343.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm7012375
Full text not available from this repository.
Friebolin, W;
Jannack, B;
Wenzel, N;
Furrer, J;
Oeser, T;
Sanchez, CP;
Lanzer, M;
Yardley, V;
Becker, K;
Davioud-Charvet, E;
(2008)
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Journal of medicinal chemistry, 51 (5).
pp. 1260-1277.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm7009292
Full text not available from this repository.
Gemma, S;
Campiani, G;
Butini, S;
Kukreja, G;
Coccone, SS;
Joshi, BP;
Persico, M;
Nacci, V;
Fiorini, I;
Novellino, E;
+12 more...
Fattorusso, E;
Taglialatela-Scafati, O;
Savini, L;
Taramelli, D;
Basilico, N;
Parapini, S;
Morace, G;
Yardley, V;
Croft, S;
Coletta, M;
Marini, S;
Fattorusso, C;
(2008)
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: Design, synthesis, and biological and structure-activity relationship studies.
Journal of medicinal chemistry, 51 (5).
pp. 1278-1294.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm701247k
Full text not available from this repository.
Musonda, CC;
Yardley, V;
de Souza, RCC;
Ncokazi, K;
Egan, TJ;
Chibale, K;
(2008)
Antiplasmodial, beta-haematin inhibition, antitrypanosomal and cytotoxic activity in vitro of novel 4-aminoquinoline 2-imidazolines.
Organic & biomolecular chemistry, 6 (23).
pp. 4446-4451.
ISSN 1477-0520
DOI: https://doi.org/10.1039/b813007h
Full text not available from this repository.
Nanayakkara, NP;
Ager, AL;
Bartlett, MS;
Yardley, V;
Croft, SL;
Khan, IA;
McChesney, JD;
Walker, LA;
(2008)
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichloropheno xy]quinoline succinate.
Antimicrobial agents and chemotherapy, 52 (6).
pp. 2130-2137.
ISSN 0066-4804
DOI: https://doi.org/10.1128/aac.00645-07
Full text not available from this repository.
Nanayakkara, NP;
Ager, ALJr;
Bartlett, MS;
Yardley, V;
Croft, SL;
Khan, IA;
McChesney, JD;
Walker, LA;
(2008)
Antiparasitic Activity and Toxicity of Individual Enantiomers of the 8-Aminoquinoline, 8-[(4-Amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline Succinate.
Antimicrobial agents and chemotherapy, 52 (6).
pp. 2130-7.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.00645-07
Full text not available from this repository.
October, N;
Watermeyer, ND;
Yardley, V;
Egan, TJ;
Ncokazi, K;
Chibale, K;
(2008)
Reversed Chloroquines Based on the 3,4-Dihydropyrimidin-2(1H)-one Scaffold: Synthesis and Evaluation for Antimalarial, beta-Haematin Inhibition, and Cytotoxic Activity.
ChemMedChem, 3 (11).
pp. 1649-1653.
ISSN 1860-7179
DOI: https://doi.org/10.1002/cmdc.200800172
Full text not available from this repository.
2007
Gemma, S;
Campiani, G;
Butini, S;
Kukreja, G;
Joshi, BP;
Persico, M;
Catalanotti, B;
Novellino, E;
Fattorusso, E;
Nacci, V;
+6 more...
Savini, L;
Taramelli, D;
Basilico, N;
Morace, G;
Yardley, V;
Fattorusso, C;
(2007)
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore.
Journal of medicinal chemistry, 50 (4).
pp. 595-8.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm061429p
Full text not available from this repository.
Gernma, S;
Kukreja, G;
Campiani, G;
Butini, S;
Bernetti, M;
Joshi, BP;
Savini, L;
Basifico, N;
Taramelli, D;
Yardley, V;
+5 more...
Bertamino, A;
Novellino, E;
Persico, M;
Catalanotti, B;
Fattorusso, C;
(2007)
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistan P-falciparum strains. Synthesis and molecular modeling.
Bioorganic & medicinal chemistry letters, 17 (13).
pp. 3535-3539.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2007.04.077
Full text not available from this repository.
Khrizman, A;
Moulthrop, JS;
Little, S;
Wharton, H;
Yardley, V;
Moyna, G;
(2007)
Synthesis and in vitro protozoocidal activity of diazabicyclic benzotropolone derivatives.
Bioorganic & medicinal chemistry letters, 17 (15).
pp. 4183-4186.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2007.05.044
Full text not available from this repository.
Khrizman, A;
Slack, RD;
Remsing, RC;
Little, S;
Yardley, V;
Moyna, G;
(2007)
Synthesis and In Vitro protozoocidal evaluation of novel diazabicyclic tropolone derivatives.
Archiv der Pharmazie, 340 (11).
pp. 569-576.
ISSN 0365-6233
DOI: https://doi.org/10.1002/ardp.200700143
Full text not available from this repository.
Musonda, CC;
Little, S;
Yardley, V;
Chibale, K;
(2007)
Application of multicomponent reactions to antimalarial drug discovery. Part 3: Discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
Bioorganic & medicinal chemistry letters, 17 (17).
pp. 4733-4736.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2007.06.070
Full text not available from this repository.
Rijal, S;
Yardley, V;
Chappuis, F;
Decuypere, S;
Khanal, B;
Singh, R;
Boelaert, M;
de Doncker, S;
Croft, S;
Dujardin, JC;
(2007)
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?
Microbes and infection / Institut Pasteur, 9 (4).
pp. 529-535.
ISSN 1286-4579
DOI: https://doi.org/10.1016/j.micinf.2007.01.009
Full text not available from this repository.
Too, K;
Brown, DM;
Bongard, E;
Yardley, V;
Vivas, L;
Loakes, D;
(2007)
Anti-malarial activity of N-6-modified purine analogues.
Bioorganic & medicinal chemistry, 15 (16).
pp. 5551-5562.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2007.05.038
Full text not available from this repository.
2006
Bauer, H;
Fritz-Wolf, K;
Winzer, A;
Kuhner, S;
Little, S;
Yardley, V;
Vezin, H;
Palfey, B;
Schirmer, RH;
Davioud-Charvet, E;
(2006)
A Fluoro Analogue of the Menadione Derivative 6-[2'-(3'-Methyl)-1',4'-naphthoquinolyl]hexanoic Acid Is a Suicide Substrate of Glutathione Reductase. Crystal Structure of the Alkylated Human Enzyme.
Journal of the American Chemical Society, 128 (33).
pp. 10784-10794.
ISSN 0002-7863
DOI: https://doi.org/10.1021/ja061155v
Full text not available from this repository.
Coro, J;
Atherton, R;
Little, S;
Wharton, H;
Yardley, V;
Alvarez, A;
Suarez, M;
Perez, R;
Rodriguez, H;
(2006)
Alkyl-linked bis-THTT derivatives as potent in vitro trypanocidal agents.
Bioorganic & medicinal chemistry letters, 16 (5).
pp. 1312-1315.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2005.11.060
Full text not available from this repository.
Croft, SL;
Seifert, K;
Yardley, V;
(2006)
Current scenario of drug development for leishmaniasis.
The Indian journal of medical research, 123 (3).
pp. 399-410.
ISSN 0971-5916
http://researchonline.lshtm.ac.uk/id/eprint/11722
Ferreira, CL;
Ewart, CB;
Barta, CA;
Little, S;
Yardley, V;
Martins, C;
Polishchuk, E;
Smith, PJ;
Moss, JR;
Merkel, M;
+2 more...
Adam, MJ;
Orvig, C;
(2006)
Synthesis, Structure, and Biological Activity of Ferrocenyl Carbohydrate Conjugates.
Inorganic chemistry, 45 (20).
pp. 8414-8422.
ISSN 0020-1669
DOI: https://doi.org/10.1021/ic061166p
Full text not available from this repository.
Gemma, S;
Kukreja, G;
Fattorusso, C;
Persico, M;
Romano, MP;
Altarelli, M;
Savini, L;
Campiani, G;
Fattorusso, E;
Basilico, N;
+3 more...
Taramelli, D;
Yardley, V;
Butini, S;
(2006)
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Bioorganic & medicinal chemistry letters, 16 (20).
pp. 5384-8.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2006.07.060
Full text not available from this repository.
Gros, L;
Castillo-Acosta, VM;
Jimenez Jimenez, C;
Sealey-Cardona, M;
Vargas, S;
Manuel Estevez, A;
Yardley, V;
Rattray, L;
Croft, SL;
Ruiz-Perez, LM;
+3 more...
Urbina, JA;
Gilbert, IH;
Gonzalez-Pacanowska, D;
(2006)
New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action.
Antimicrobial agents and chemotherapy, 50 (8).
pp. 2595-601.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.01508-05
Full text not available from this repository.
Gros, L;
Lorente, SO;
Jimenez, CJ;
Yardley, V;
Rattray, L;
Wharton, H;
Little, S;
Croft, SL;
Ruiz-Perez, LM;
Gonzalez-Pacanowska, D;
+1 more...
Gilbert, IH;
(2006)
Evaluation of Azasterols as Anti-Parasitics.
Journal of medicinal chemistry, 49 (20).
pp. 6094-6103.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm060290f
Full text not available from this repository.
Hudock, MP;
Sanz-Rodriguez, CE;
Song, YC;
Chan, JMW;
Zhang, YH;
Odeh, S;
Kosztowski, T;
Leon-Rossell, A;
Concepcion, JL;
Yardley, V;
+3 more...
Croft, SL;
Urbina, JA;
Oldfield, E;
(2006)
Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.
Journal of medicinal chemistry, 49 (1).
pp. 215-223.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm0582625
Full text not available from this repository.
Laurent, T;
Rijal, S;
Yardley, V;
Croft, S;
De Doncker, S;
Decuypere, S;
Khanal, B;
Singh, R;
Schönian, G;
Kuhls, K;
+2 more...
Chappuis, F;
Dujardin, JC;
(2006)
Epidemiological dynamics of antimonial resistance in Leishmania donovani: Genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal.
Infection, genetics and evolution, 7 (2).
pp. 206-12.
ISSN 1567-1348
DOI: https://doi.org/10.1016/j.meegid.2006.08.005
Full text not available from this repository.
Musonda, CC;
Gut, J;
Rosenthal, PJ;
Yardley, V;
Carvalho de Souza, RC;
Chibale, K;
(2006)
Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.
Bioorganic & medicinal chemistry, 14 (16).
pp. 5605-15.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2006.04.035
Full text not available from this repository.
Tasdemir, D;
Brun, R;
Yardley, V;
Franzblau, SG;
Rüedi, P;
(2006)
Antituberculotic and antiprotozoal activities of primin, a natural benzoquinone: in vitro and in vivo studies.
Chemistry & biodiversity, 3 (11).
pp. 1230-7.
ISSN 1612-1872
DOI: https://doi.org/10.1002/cbdv.200690124
Full text not available from this repository.
Tasdemir, D;
Kaiser, M;
Brun, R;
Yardley, V;
Schmidt, TJ;
Tosun, F;
Ruedi, P;
(2006)
Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
Antimicrobial agents and chemotherapy, 50 (4).
pp. 1352-64.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.50.4.1352-1364.2006
Full text not available from this repository.
Yardley, V;
Ortuno, N;
Llanos-Cuentas, A;
Chappuis, F;
Doncker, SD;
Ramirez, L;
Croft, S;
Arevalo, J;
Adaui, V;
Bermudez, H;
+2 more...
Decuypere, S;
Dujardin, JC;
(2006)
American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
The Journal of infectious diseases, 194 (8).
pp. 1168-75.
ISSN 0022-1899
DOI: https://doi.org/10.1086/507710
Full text not available from this repository.
2005
Baliani, A;
Bueno, GJ;
Stewart, ML;
Yardley, V;
Brun, R;
Barrett, MP;
Gilbert, IH;
(2005)
Design and Synthesis of a Series of Melamine-based Nitroheterocycles with Activity against Trypanosomatid Parasites.
Journal of medicinal chemistry, 48 (17).
pp. 5570-5579.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm050177+
Full text not available from this repository.
Decuypere, S;
Rijal, S;
Yardley, V;
de Doncker, S;
Laurent, T;
Khanal, B;
Chappuis, F;
Dujardin, JC;
(2005)
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal.
Antimicrobial agents and chemotherapy, 49 (11).
pp. 4616-4621.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.49.11.4616-4621.2005
Full text not available from this repository.
Decuypere, S;
Vandesompele, J;
Yardley, V;
De Donckeri, S;
Laurent, T;
Rijal, S;
Llanos-Cuentas, A;
Chappuis, F;
Arevalo, J;
Dujardin, JC;
(2005)
Differential polyadenylation of ribosomal RNA during post-transcriptional processing in Leishmania.
Parasitology, 131 (Pt 3).
pp. 321-9.
ISSN 0031-1820
DOI: https://doi.org/10.1017/s0031182005007808
Lee, B;
Bauer, H;
Melchers, J;
Ruppert, T;
Rattray, L;
Yardley, V;
Davioud-Charvet, E;
Krauth-Siegel, RL;
(2005)
Irreversible Inactivation of Trypanothione Reductase by Unsaturated Mannich Bases: A Divinyl Ketone as Key Intermediate.
Journal of medicinal chemistry, 48 (23).
pp. 7400-7410.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm0504860
Full text not available from this repository.
Lorente, SO;
Gomez, R;
Jimenez, C;
Cammerer, S;
Yardley, V;
de Luca-Fradley, K;
Croft, SL;
Perez, LMR;
Urbina, J;
Pacanowska, DG;
+1 more...
Gilbert, IH;
(2005)
Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
Bioorganic & medicinal chemistry, 13 (10).
pp. 3519-3529.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2005.02.060
Full text not available from this repository.
Lorente, SO;
Jimenez, CJ;
Gros, L;
Yardley, V;
de Luca-Fradley, K;
Croft, SL;
Urbina, JA;
Ruiz-Perez, LM;
Pacanowska, DG;
Gilbert, IH;
(2005)
Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasities.
Bioorganic & medicinal chemistry, 13 (18).
pp. 5435-5453.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2005.06.012
Full text not available from this repository.
Parveen, S;
Khan, MO;
Austin, SE;
Croft, SL;
Yardley, V;
Rock, P;
Douglas, KT;
(2005)
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.
Journal of medicinal chemistry, 48 (25).
pp. 8087-97.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm050819t
Full text not available from this repository.
Yardley, V;
Croft, SL;
DE Doncker, S;
Dujardin, JC;
Koirala, S;
Rijal, S;
Miranda, C;
Llanos-Cuentas, A;
Chappuis, F;
(2005)
THE SENSITIVITY OF CLINICAL ISOLATES OF LEISHMANIA FROM PERU AND NEPAL TO MILTEFOSINE.
The American journal of tropical medicine and hygiene, 73 (2).
pp. 272-5.
ISSN 0002-9637
http://researchonline.lshtm.ac.uk/id/eprint/13280
2004
Camacho, MD;
Phillipson, JD;
Croft, SL;
Yardley, V;
Solis, PN;
(2004)
In vitro antiprotozoal and cytotoxic activities of some alkaloids, quinones, flavonoids, and coumarins.
Planta medica, 70 (1).
pp. 70-72.
ISSN 0032-0943
DOI: https://doi.org/10.1055/s-2004-815460
Full text not available from this repository.
Grant, KM;
Dunion, MH;
Yardley, V;
Skaltsounis, AL;
Marko, D;
Eisenbrand, G;
Croft, SL;
Meijer, L;
Mottram, JC;
(2004)
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: Chemical library screen and antileishmanial activity.
Antimicrobial agents and chemotherapy, 48 (8).
p. 3033.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.48.8.3033-3042.2004
Full text not available from this repository.
Jung, M;
Lee, K;
Jung, H;
Kendrick, H;
Yardley, V;
Croft, SL;
(2004)
Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Bioorganic & medicinal chemistry letters, 14 (8).
p. 2001.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2003.12.104
Full text not available from this repository.
Lorente, SO;
Rodrigues, JCF;
Jimenez, CJ;
Joyce-Menekse, M;
Rodrigues, C;
Croft, SL;
Yardley, V;
de Luca-Fradley, K;
Ruiz-Perez, LM;
Urbina, J;
+3 more...
de Souza, W;
Pacanowska, DG;
Gilbert, IH;
(2004)
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
Antimicrobial agents and chemotherapy, 48 (8).
p. 2937.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.48.8.2937-2950.2004
Full text not available from this repository.
Nan, A;
Croft, SL;
Yardley, V;
Ghandehari, H;
(2004)
Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis.
Journal of controlled release, 94 (1).
pp. 115-127.
ISSN 0168-3659
DOI: https://doi.org/10.1016/j.jconrel.2003.09.012
Full text not available from this repository.
2003
Kayser, O;
Olbrich, C;
Yardley, V;
Kiderlen, AF;
Croft, SL;
(2003)
Formulation of amphotericin B as nanosuspension for oral administration.
International journal of pharmaceutics, 254 (1).
pp. 73-75.
ISSN 0378-5173
DOI: https://doi.org/10.1016/s0378-5173(02)00686-5
Full text not available from this repository.
Larabi, M;
Yardley, V;
Loiseau, PM;
Appel, M;
Legrand, P;
Gulik, A;
Bories, C;
Croft, SL;
Barratt, G;
(2003)
Toxicity and Antileishmanial Activity of a New Stable Lipid Suspension of Amphotericin B.
Antimicrobial agents and chemotherapy, 47 (12).
pp. 3774-3779.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.47.12.3774-3779.2003
Full text not available from this repository.
Lawn, SD;
Yardley, V;
Vega-Lopez, F;
Watson, J;
Lockwood, DN;
(2003)
New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 97 (4).
p. 443.
ISSN 0035-9203
DOI: https://doi.org/10.1016/S0035-9203(03)90084-8
Full text not available from this repository.
Magaraci, F;
Jimenez, CJ;
Rodrigues, C;
Rodrigues, JCF;
Braga, MV;
Yardley, V;
de Luca-Fradley, K;
Croft, SL;
de Souza, W;
Ruiz-Perez, LM;
+3 more...
Urbina, J;
Pacanowska, DG;
Gilbert, IH;
(2003)
Azasterols as inhibitors of sterol 24-methyltransferase in leishmania species and Trypanosoma cruzi.
Journal of medicinal chemistry, 46 (22).
pp. 4714-4727.
ISSN 0022-2623
DOI: https://doi.org/10.1021/jm021114j
Full text not available from this repository.
Pez, D;
Leal, I;
Zuccotto, F;
Boussard, C;
Brun, R;
Croft, SL;
Yardley, V;
Perez, LMR;
Pacanowska, DG;
Gilbert, IH;
(2003)
2,4-diaminopyrimidines as inhibitors of leishmanial and trypanosomal dihydrofolate reductase.
Bioorganic & medicinal chemistry, 11 (22).
pp. 4693-4711.
ISSN 0968-0896
DOI: https://doi.org/10.1016/j.bmc.2003.08.012
Full text not available from this repository.
Ren, HY;
Grady, S;
Banghart, M;
Moulthrop, JS;
Kendrick, H;
Yardley, V;
Croft, SL;
Moyna, G;
(2003)
Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazines.
European journal of medicinal chemistry, 38 (11-12).
p. 949.
ISSN 0223-5234
DOI: https://doi.org/10.1016/s0223-5234(03)00180-6
Full text not available from this repository.
2002
Croft, SL;
Yardley, V;
(2002)
Chemotherapy of leishmaniasis.
Current pharmaceutical design, 8 (4).
pp. 319-42.
ISSN 1381-6128
DOI: https://doi.org/10.2174/1381612023396258
Full text not available from this repository.
Croft, SL;
Yardley, V;
Kendrick, H;
(2002)
Drug sensitivity of Leishmania species: some unresolved problems.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 96 Sup.
S127-9.
ISSN 0035-9203
http://researchonline.lshtm.ac.uk/id/eprint/16578
Full text not available from this repository.
Yardley, V;
Khan, AA;
Martin, MB;
Slifer, TR;
Araujo, FG;
Moreno, SN;
Docampo, R;
Croft, SL;
Oldfield, E;
(2002)
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.
Antimicrobial agents and chemotherapy, 46 (3).
pp. 929-31.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.46.3.929-931.2002
Full text not available from this repository.
2001
Asres, K;
Bucar, F;
Knauder, E;
Yardley, V;
Kendrick, H;
Croft, SL;
(2001)
In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle.
Phytotherapy research, 15 (7).
pp. 613-7.
ISSN 0951-418X
http://researchonline.lshtm.ac.uk/id/eprint/16573
Full text not available from this repository.
Chibale, K;
Haupt, H;
Kendrick, H;
Yardley, V;
Saravanamuthu, A;
Fairlamb, AH;
Croft, SL;
(2001)
Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine.
Bioorganic & medicinal chemistry letters, 11 (19).
pp. 2655-2657.
ISSN 0960-894X
DOI: https://doi.org/10.1016/S0960-894X(01)00528-5
Full text not available from this repository.
Daunes, S;
D'Silva, C;
Kendrick, H;
Yardley, V;
Croft, SL;
(2001)
QSAR study on the contribution of log P and E-s to the in vitro antiprotozoal activity of glutathione derivatives.
Journal of medicinal chemistry, 44 (18).
pp. 2976-83.
ISSN 0022-2623
http://researchonline.lshtm.ac.uk/id/eprint/16567
Full text not available from this repository.
Escobar, P;
Yardley, V;
Croft, SL;
(2001)
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Antimicrobial agents and chemotherapy, 45 (6).
pp. 1872-5.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.45.6.1872-1875.2001
Full text not available from this repository.
Martin, MB;
Grimley, JS;
Lewis, JC;
Heath, HT;
Bailey, BN;
Kendrick, H;
Yardley, V;
Caldera, A;
Lira, R;
Urbina, JA;
+4 more...
Moreno, SNJ;
Docampo, R;
Croft, SL;
Oldfield, E;
(2001)
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy.
Journal of medicinal chemistry, 44 (6).
pp. 909-16.
ISSN 0022-2623
http://researchonline.lshtm.ac.uk/id/eprint/16563
Full text not available from this repository.
Nan, A;
Nanayakkara, NPD;
Walker, LA;
Yardley, V;
Croft, SL;
Ghandehari, H;
(2001)
N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs.
Journal of controlled release, 77 (3).
pp. 233-43.
ISSN 0168-3659
http://researchonline.lshtm.ac.uk/id/eprint/16572
Full text not available from this repository.
Ren, HY;
Grady, S;
Gamenara, D;
Heinzen, H;
Moyna, P;
Croft, SL;
Kendrick, H;
Yardley, V;
Moyna, G;
(2001)
Design, synthesis, and biological evaluation of a series of simple and novel potential antimalarial compounds.
Bioorganic & medicinal chemistry letters, 11 (14).
pp. 1851-1854.
ISSN 0960-894X
DOI: https://doi.org/10.1016/S0960-894X(01)00308-0
Full text not available from this repository.
Salmon-Chemin, L;
Buisine, E;
Yardley, V;
Kohler, S;
Debreu, MA;
Landry, V;
Sergheraert, C;
Croft, SL;
Krauth-Siegel, RL;
Davioud-Charvet, E;
(2001)
2-and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
Journal of medicinal chemistry, 44 (4).
pp. 548-65.
ISSN 0022-2623
http://researchonline.lshtm.ac.uk/id/eprint/16559
Full text not available from this repository.